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ABSTRACT  
Quantitative multinuclear HRMAS was performed in order to determine the tissue pH and the absolute 
metabolic concentration of 33 samples of human brain tumour tissue. Metabolite concentration 
quantification was obtained by 1D 1H and 31P HRMAS using the ERETIC synthetic signal. 1H-1H 
homonuclear and 1H-31P heteronuclear correlation experiments enabled the direct assessment of the 1H-
31P spin systems of those signals overlapped in the 1H 1D spectra, and connected the information among 
the 1H and 31P 1D spectra. Afterwards, the main histological features were determined and a high 
heterogeneity in the content of tumour, necrosis and not affected tissue proportions was observed. The 
metabolic profiles obtained by HRMAS showed the typical characteristics found in tumoral tissues, a 
depletion of energetic molecules and increment of concentrations of protective metabolites. Nevertheless, 
these conditions correlated with the total amount of living tissue better than only with tumoral cells 
content of the samples which could indicate an important contribution of the sampling conditions respect 
to the tumoral effect developed in vivo. The use of MDPA as a chemical shift and concentration reference 
for 31P HRMAS spectra of tissues presented important drawbacks due to the interaction with the tissue. 
Moreover, the pH data obtained from 31P enabled to establish a correlation between the pH and the 
distance of the N(CH3)3 signals of Phosphocholine and Choline in 1H spectra in the tissue of these tumour 
samples. 
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aminobutiric acid; Tau, taurine; mI, myo-inositol; Gly, Glycine; FA, fatty acids; NAT, non affected 
tissue.    
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INTRODUCTION 
High-resolution magic angle spinning (HRMAS) NMR has become in recent years a valuable technique 
to obtain detailed metabolic profiles of human brain tumours [1-6]. There is a widespread use of 1H 1D 
spectra to quantify the metabolites [1-3, 6, 7]. 2D 1H -1H homonuclear or 1H -13C heteronuclear 
experiments have improved the assignments in HRMAS spectra [3-5, 8] but the quantitative metabolic 
information comes mainly from the 1H 1D spectra. The use of 31P NMR spectroscopy has also been 
demonstrated to be useful in the metabolomic study of brain cancer since there are 31P-containing 
metabolites that can provide valuable information complementary to 1H NMR in metabolic studies [9-11]. 
In this context, 31P NMR spectra can inform about typical membrane components as the 
phosphomonoesters (PME) phosphoethanolamine (PE) and phospocholine (PC),  mobile phosphodiesters 
(PDE) as glycerophosphorylethanolamine (GPE) and glycerophosphocholine (GPC) and less mobile 
phospholipids, as well as important energetic metabolism intermediates as phosphocreatine (PCr) and 
nucleotides-phosphate [9, 10, 12]. Moreover, the pH can be inferred from the changes in the chemical 
shift of some 31P-metabolites [9, 10, 13]. In vivo, the pH is usually determined using the chemical shift of 
Pi signal relative to PCr, whose chemical shift is pH-independent in the physiologic range of pH [9, 14]. 
The in vivo pHi in brain tumours has been observed slightly more alkaline than that of normal brain [9, 
10, 15].  
HRMAS allows the study 1H and 31P-metabolites in the tissue and may provide information about the 
tissue pH. But the number of 31P HRMAS studies of human cancer tissue is scarce. The suitability of this 
technique to detect 31P metabolites and to determine the pH in tumour tissue has been demonstrated in 
experimental tumours in mice and mouse brain [16]. In humans, 1H and 31P 1D HRMAS experiments 
have been used to study the changes in cervical cancer and have showed a higher content of PC and PE in 
cancer tissue compared to normal tissue [17]. The combined use of 1H and 31P 1D HRMAS experiments 
has been also reported in human samples of gut biopsies [18] to reveal changes between different tissue 
microenvironment using 1D 1H and 31P spectra to construct virtual 2D heteronuclear correlation spectra 
that connect all protons on the molecule to the heteroatom [18]. It has been observed that in the ex vivo 
31P spectra of tissues there are no significant signals from the high-energy phosphates (ATP or PCr) due 
to the rapid metabolism either during the sample preparation or during the spinning [16, 17]. Thus, the 
use of PCr as chemical shift reference as usually performed in vivo 31P NMR spectroscopy is not possible 
in 31P-HRMAS experiments, and the changes in chemical shift with pH for several 31P-metabolites make 
sometimes challenging the assignment of the signals and hence the determination of the tissue pH. This 
fact motivates the use of 31P reference compounds (as 3-aminopropyl phosphonate [16], phosphono-
methyl-glycerol [19], dimethyl phosphonic acid [20] or methylene-diphosphonic acid [16] (MDPA)) for 
the chemical shift that could be also a reference for the concentration. This might be useful in the NMR 
studies of liquid extracts since the external reference can be introduced in a capillary in the NMR tube, 
isolated from the sample. Nevertheless, a similar strategy in HRMAS is limited by the possible interaction 
between the reference and the sample (both, the tissue sample and the exogenous reference are in the 
same compartment inside the rotor) which in terms of quantization produces large variation in the 
measured peak areas for the reference compound [16]. 
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The study of human brain tumour tissue by 1H 1D and 1H-decoupled 31P HRMAS and posterior 
histological study will be here presented, including the evaluation of the pH for each sample and the 
acquisition of real 2D 1H-1H homonuclear and 1H-31P heteronuclear HRMAS experiments for the direct 
assessment of overlapped signals in the 1H 1D spectra. Moreover, the use of MDPA as a reference for 
chemical shift and quantification will be here discussed and the influence in the pH of the biopsy sample. 
The ERETIC signal as a reference for NMR spectra quantification[21] has been already tested in 1H 
spectra of human tissues either using either an external electronically generated reference [7, 22] or using 
a synthetic signal [23], but the use of the ERETIC signal has never been tested to evaluate 31P metabolite 
concentrations in tissues. The use of ERETIC synthetic signal [23] will be here proposed as a reference to 
quantify the metabolites in 1H and also in 31P spectra of tissues. The quantitative information of 1H and 
31P 1D will enable, on one hand confirm the robustness of the ERETIC method comparing the calculated 
concentration for those metabolites whose signals can be properly integrated in both 1H and 31P 1D 
experiments, and on the other hand, will complete the quantitative information for those metabolites 
whose signals are challenging to integrate in 1H and can be properly integrated in 31P as 
Phosphoethanolamine and Glycerophosphorylethanolamine. The correlation among the metabolites and 
between the metabolites, the pH and the histological features will be also discussed. Finally, preliminary 
considerations of slight changes in 1H chemical shift with the pH observed in these spectra will be also 
presented.  
EXPERIMENTAL: 
This study involves the use of human brain tumour biopsy samples. It was reviewed and approved by the 
ethics committee of the Hospital de la Ribera, Alzira, Spain. Thirty-three patients underwent surgical 
resection of a brain tumour. After surgery, part of the resected tissue was sent for routine histological 
analysis and the remaining was stored at -80ºC until the time of spectroscopic analysis. In the histological 
analysis 27 tumours were identified as glial tumours and 6 as non glial tumours. The glial tumours group 
included 19 grade IV glioma (GBM), 2 grade III gliomas (1 anaplastic astrocytoma, and 1 anaplastic 
oligodendroastrocytoma), 2 grade II gliomas (1 oligodendroglioma and 1 oligoastrocytoma) and 4 grade I 
astrocytoma. Non glial tumours included 2 metastases (1 bowel adenocarcinoma, and 1 breast cancer), 3 
meningeomas and one teratoma grade III. The Table S1 (see Electronic Supplementary Material) shows a 
list of the samples and the tumour type according to the histology classification for tumour diagnosis. 
HRMAS of tissue, sample preparation and spectra acquisition 
The samples were studied by HRMAS inside 4mm/50μL ZrO2 rotors in a 11.7 T magnet (Bruker Avance 
DRX 500 spectrometer) operating at 500.13 MHz for 1H and at 202 MHz for 31P. The instrument was 
equipped with a 4 mm triple resonance 1H/31P/13C HRMAS probe. The amount of tumour tissue studied 
for each patient ranged from 8.0 to 34.1 mg. The Table 1 shows the weight average and standard 
deviation for each group of tumours. The Table S1 (see Electronic Supplementary Material) shows in 
detail the weight for each one of the samples. The samples were introduced in the rotor without flushing, 
thus avoiding the leakage of metabolites reported in the washing of tissues [24, 25]. In 14 samples, 10 μL 
of methylene diphosphonic acid (MDPA) 10 mM in D2O were added. In all the samples (33 samples) the 
volume of the rotor was completed with cold D2O as a field frequency lock. The samples were spun at 
4000 Hz in order to keep the rotation sidebands out of the acquisition window. A Bruker cooling unit was 
used to control the temperature by cooling down the bearing air flowing into the probe. In all the 
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experiments, the sample temperature was 6ºC as determined by internal measurement using a 100% 
methanol sample in a 4mm/50μL ZrO2 rotor spinning at the same frequency. The shimming was 
optimized checking the quality of the signals and the resolution of the alanine (Ala) doublet (doublet from 
CH3 protons at 1.465 ppm) in the 1H spectra, present in all the samples analyzed.  
For each sample, one-dimensional (1D) 1H spectra with presaturation in the water signal (from now on 1H 
spectra) and 1D 1H-decoupled 31P HRMAS spectra (from now on 31P spectra) were acquired. Water 
presaturation 1H spectra using a 1.36 s acquisition time, 256 transients, a 6000 Hz spectral width, and a 
relaxation delay of 1 s were acquired in 10 min. 1H-decoupled 31P spectra were acquired in 1 hour, using a 
1.61 s acquisition time, 1024 transients, a 10162 Hz spectral width, a relaxation delay of 2 s and proton 
decoupling.  
Additional 1H-1H 2D homonuclear spectra Hartman-Hahn transfer using DIPSI2 sequence for mixing 
(from now on TOCSY spectrum) was acquired in 22 samples in order to identify the spin systems and to 
assess the 1H assignments [26]. The TOCSY spectra were obtained in 2 hours, with 2 s water 
presaturation, 16 transients. The TOCSY mixing time was 50 ms. 1H-31P 2D heteronuclear correlation 
experiments (from now on 1H-31P HSQC spectra) were also acquired in 24 of the samples. These 
experiments were acquired with double inept transfer and TPPI for phase-sensitive detection using a 500 
ms acquisition time with decoupling and a 2 s relaxation delay. A total of 128 transients were averaged 
for each of 128 increments during t1, corresponding to a total acquisition time of 13 h. 
HRMAS spectra processing 
The 1H spectra were processed with 2-Hz exponential apodisation, Fourier transformation and phase 
correction. The 31P spectra were processed with 3-Hz exponential apodisation, Fourier transformation and 
phase correction. TOCSY and 1H 31P HSQC spectra were 2D transformed, phase and baseline corrected.  
In order to compare the metabolic content in the different samples and to obtain absolute concentration 
values of 1H and 31P metabolites, a synthetic digital ERETIC signal was added in the last step of 
processing of the 1H and 31P spectra at 10 ppm [23]. Finally, the baseline of the spectra was corrected 
using ABios program [27]. 
Standard solution for quantification and referencing 
To establish the value of the synthetic signal of ERETIC for 1H and 31P spectra and to assess the 
assignment of 31P signals and pH calculation, 2 solutions 20 mM in PCr and 12 mM in PC were prepared 
with pH 6.34 and 7.19. The PCr started to decompose in Cr and Pi in some extent before NMR 
measurement, so the solutions contained PC 12 mM, PCr and Pi, with [PCr+Pi] = 20 mM. The same 
experimental conditions of probe, rotor, spinning and temperature used for the tissue studies were applied 
for these standard solution samples at these 2 pH.  
HRMAS spectra referencing 
The chemical shifts in 1H spectra were referenced to the Creatine (Cr) CH3 singlet at 3.027 ppm and to 
the Ala CH3 doublet at 1.465 ppm. The chemical shifts in the 31P spectra of tissue were referenced to the 
GPC peak at 0.48 ppm, when detectable. The 31P chemical shift of this compound is independent of the 
pH [14], thus, using this reference, the same offset was applied for all the 31P spectra. This strategy was 
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checked with all the spectra that contained GPC. The 1H and 31P spectra in the Figure 1 show the 
assignments for the metabolites studied in the tissues for three samples with different kind of tissue. 
The chemical shifts in the TOCSY spectra were referenced to the Ala CH3/CH crosspeak at 1.47-3.77 
ppm. The chemical shifts in the 1H-31P HSQC spectra were referenced to the GPC CH2/P crosspeak at 
4.32-0.48. This CH2 is the closest CH2 to the Phosphate group in the choline moiety of GPC molecule. 
The assignment of the homo and heteronuclear crosspeaks of GPC, GPE, PC and PE are displayed in the 
Figure 2, together with the structure of each of these molecules. 
Spectra quantification and analysis 
The 1H and 31P spectra were analysed with ABios [27]. Then, the peaks were finally assigned accounting 
for the deviation in chemical shifts and peaks widths. The resonances for the most common metabolites, 
lipids and macromolecules, and for ERETIC synthetic signal were integrated adjusting them to a 
Gaussian or Lorentzian function and the overlapping was corrected by using a least square minimization 
algorithm incorporated in the ABios program [27].  
Histology post HRMAS 
In order to determine the proportion of tumour %Tum, necrosis %Nec or normal appearing tissue %NAT 
the samples underwent histological analysis after the HRMAS experiments. The samples were immersed 
in 10% formalin. Once fixed, the tissue specimens were embedded in paraffin and the tissue pieces were 
serially sectioned in slices of 5 µm and H & E stained. The image analysis and measurements were 
carried out using ImageJ software [28]. The Figure 1 shows the slices of three biopsy sample tumours 
with different proportion of Tum, Nec and NAT (sample 1: 4% Tum, 96.0% Nec, 0.0% NAT, sample 7: 
94.2% Tum, 5.8% Nec, 0.0% NAT, sample 10: 46.1% Tum, 1.0% Nec, 52.8% NAT) together with the 1H 
and 31P spectra. The Table 1 shows the average and the standard deviation of the content of Tum, Nec and 
NAT for each group of tumours. The histological data for each sample is detailed in Table S1 (see 
Electronic Supplementary Material). 
Statistics 
ANOVA analysis and correlation among metabolite concentration, pH and histological data was 
performed using ABios [27] which implemented MATLAB statistical libraries.  
 
RESULTS 
1H and 31P spectra assignation and pH calculation 
The metabolites in 1H spectra were assigned using the data in the literature [4, 29, 30] and the TOCSY 
and 1H-31P HSQC spectra acquired for the same samples. The metabolites identified in the 1H spectra 
were GPC, PC, choline (Cho), Cr, lactate (Lac), Ala, Glutamate (Glu), Glutamine (Gln), Glutathione 
(GSH), N-Acetylaspartate (NAA), γ-aminobutiric acid (GABA), taurine (Tau), myo-inositol (mI) and 
Glycine (Gly) in the aliphatic region. Between 6 and 10 ppm the signals were assigned to the NH2 groups 
of Gln, the NH group of Cr and to the resonances H1’ of ribose, and the protons H2 and H8 in the ring of 
adenine in adenosine-3-phosphate (Ade). The assignments of adenosine-3-phosphate were confirmed by 
comparison with the spectra of the same compound downloaded from BMRB [31]. The broad resonances 
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of macromolecules and fatty acids in 1H spectra were assigned using the data in the literature [32-35]. The 
1H assignments for the metabolites and FA are shown in the Figure 1. 
In the 31P spectra, once assigned GPC signal at 0.48 ppm, the pH was calculated using the chemical shift 
distance between the Pi signal and the GPC peak [14, 16]. According to this, the calculated pH of each 
sample is shown in the Table S1 (see Electronic Supplementary Material). The pH average and standard 
deviation for each group of tumours is shown in the Table 1. Once estimated the pH, the expected 31P 
chemical shifts of PE, PC and GPE were calculated for each sample. Then, the signals in the 31P spectra 
were assigned using these calculated chemical shifts. The 31P spectra assignments of metabolites are 
shown in the Figure 1. 
This strategy for pH and chemical shift calculation in 31P spectra was tested in the standard solutions with 
PC, PCr and Pi, prepared at pH 7.19 and 6.34. The pH for each solution was calculated using the ppm 
distance between Pi and PCr [36], and the chemical shifts of PCr and PC were calculated depending on 
the pH, following the same procedures used for the tissue samples [14]. According to the pH determined 
by the electrode, the pH calculated using the chemical shifts showed an error lower than 5% (7.24 
calculated for pH=7.19, error 0.7%, 6.77 calculated for pH=6.34, error 4.7%), validating thus this 
procedure to calculate the pH and the 31P chemical shifts. 
In the tissue spectra, the signals of PE and GPE clearly observed in some of the 31P spectra were not 
always evident in the 1H spectra for the same samples, due to the overlapping of the signals in this 
crowded region of the spectra. TOCSY and 1H-31P HSQC spectra were especially useful to assess the 
presence of PE and GPE in 1H spectra given the presence of these signals in 31P spectra. Moreover, 1H-31P 
HSQC helped to assess the 1H and 31P spectra assignments and to link the information from 1H and 31P 
spectra, combining the information of both nuclei for the same metabolite in the tissue. The path for the 
assignment of ‘hidden’ signals in the 1H spectra is shown in the Figure 2 for GPC, GPE, PC and GPE. 
Evaluation of MDPA signal 
The signal of MDPA in the 31P spectra showed a remarkable variation not only in the chemical shift but 
also the in the intensity and in the width. The theoretical concentration of MDPA introduced in each rotor 
was 1x10-7 mol. Given that the volume inside the rotor was 50 µL, the expected concentration of MDPA 
was 2.00 µM. The average experimental concentration calculated for MDPA in the samples was 1.98 ± 
0.31 μM, ranging from 1.35 μM (sample 5) to 2.49 μM (sample 2) as shown in the Table S2A (see 
Electronic Supplementary Material). Despite the fact that the average concentration of MDPA was very 
close to the expected value, these data clearly showed a high deviation to consider MDPA as a 
concentration reference. The changes in the concentration of MDPA did not show any correlation with 
the pH or the mass of the tissue inside the rotor, but there was a significant correlation (-0.59 p = 0.032) 
between the detected concentration of MDPA and the amount of tumour (% of tumour x sample weight). 
Regarding to the chemical shift of MDPA, the average chemical shift of this signal was 16.63 ± 0.05 ppm 
ranging from 16.55 ppm for the sample 9 to 16.72 ppm for the sample 8 (data not shown). The changes in 
the chemical shift of MDPA showed a strong correlation with the pH (0.94 p < 0.001). The width of the 
peak of MDPA ranged between 7.12 Hz (sample 24) and 11.66 Hz (sample 5) with an average value of 
9.72 ± 1.31 Hz (data not shown). The changes in the width were highly correlated with the pH (0.57 p = 
0.035) and also with the mass of the tissue sample inside the rotor (0.68 p=0.007).  
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Histological features after HRMAS 
The areas of tumour content, necrosis and not apparently tumour were identified in the tissue slices, and 
were quantified yielding a final percentage of each of them per sample. A broad distribution of tumor and 
necrotic areas was found in the histological inspection, as seen in the data of % of viable tumor content 
(%Tum), necrosis (%Nec) and not apparently tumor (%NAT) in the Table 1for each tumor type (the data 
for each sample is shown in the Table S1 in the Electronic Supplementary Material).  
Evaluation of metabolites concentration 
The digital ERETIC signal equivalence in number of mol was calculated for 1H and 31P spectra according 
to the signal intensity in the solution 12 mM in PC at pH 7.19. According to this, the integral of the tissue 
metabolites in 1H and 31P spectra was translated into number of micro moles per gram of tissue (µmol/g) 
as a measure of absolute concentration for the comparison among the different samples, accounting for 
the number of 1H or 31P atoms integrated in each resonance. The average concentration in each tumour 
type is shown in the Table 2 for each metabolite. The calculated concentrations for each sample are 
shown in Table S2A (see Electronic Supplementary Material). For some metabolites (as Cr, Lac, Glu, Gln 
and Ade) more than one signal was assigned and hence integrated. As a proof of the robustness of the 
ERETIC digital synthetic signal calibration for 1H and 31P spectra, the correlation between the intensities 
of the different resonances for the same metabolite was very high, as it is shown in the Figure 3 for the 
CH3 and CH2 peaks in the Cr (0.95 p < 0.001). These correlations have been found when all nearby 
overlapped peaks have been fitted in the integration as shown in the Figure 3 for the Cr CH2 resonance. 
Therefore, given the equivalence between all the signals in one metabolite, only one signal per metabolite 
was included in the Table 2.  
The broad peaks corresponding to fatty acids (FA) were integrated and the tabulated values reflect an 
estimation of the number of protons implied in each peak (for FA integration in each sample see Table 
S2B in Electronic Supplementary Material). The average intensity of each FA resonance for the different 
tumour types is shown in the Table 2. 
The agreement between 31P and 1H spectra concentration estimations was checked for GPC and PC, 
which showed correlation coefficients of 0.81 (p < 0.001) for GPC and 0.94 (p < 0.001) for PC in the 
whole set of tumours (see the Figure 3). 
Changes in the concentration of metabolites, the pH and the histological content 
A great variation in the metabolite concentrations was observed over the whole set of samples (the 
coefficient of variation was always greater than 50%). The lowest variations were found for Pi, Lac and 
Tau. The metabolites with the highest variations were FA, NAA and GPE, followed by GABA, GPC and 
GSH. FA labelled with number 4 in the Tables 2, and S2B (-CH2-CH=CH-) showed a variation much 
lower than the other FA signals, probably due to other contributing signals at the same chemical shift. 
The correlations among the metabolite concentrations, the pH and the histological data post-HRMAS 
with p<0.01 are shown in the Table 3 for the whole set of tumours (for the complete set of significant 
correlations with r coefficients and p values lower than 0.05 see Table 3A in Electronic Supplementary 
Material) . The concentrations of NAA, Cr, GABA, GPE, GPC, Glu and Ade were positively correlated 
among them. The concentrations of NAA, GPE, GABA, Cr (p<0.01) and Glu (p<0.05) were highly 
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correlated to the %NAT. The concentrations of the group of fatty acids correlated highly among them, as 
it was expected (for the complete set of significant correlations with r coefficients and p values lower than 
0.05 for fatty acids see Table 3B in Electronic Supplementary Material). Moreover, there was a positive 
correlation of fatty acids with the %Nec (p<0.01) and negative with the %Tum (see data in the Table 3B 
in Electronic Supplementary Material). On the contrary, Gln showed a positive correlation with %Tum 
(0.42 p<0.05) and a negative correlation with the %Nec (-0.49 p<0.01). The %Nec correlated negatively 
with Cr, Gln, GABA, Ade (p<0.01), and GPC (p<0.05) and positively only with the fatty acids (p<0.01). 
The pH showed a negative correlation with the concentrations of Ade, Cr, NAA and GPE (p<0.01). No 
correlation was observed between the pH and the histological features in this group. 
When the analysis was restricted to the GBM group the map of significant correlations was modified. The 
Table 4 shows the correlations among the metabolite concentrations, the pH and the histological data 
post-HRMAS with p<0.01in the GBM group. The number of correlations between the tissue features and 
the metabolites was increased (see Table S4 in the Electronic Supplementary Material for the complete 
set of significant correlations with r coefficients and p values lower than 0.05). For instance, the %Tum 
for the whole group of biopsies correlated significantly only with Gln (0.42 p<0.05). However, restricting 
to the GBM group the %Tum correlated also positively with PC, GSH and mI (moreover Gln) (p<0.05), 
and negatively with FA (p<0.05). Likewise, the %Nec that was correlated negatively with Cr, Gln, 
GABA, Ade (p<0.01), and GPC (p<0.05) for all the biopsy samples, showed a general increment in the 
number of correlations for the GBM group and additional negative correlations aroused enclosing the 
intensity of PC, Lac, Glu, GSH, and mI (p<0.05) (see Table S4 in Electronic Supplementary Material). 
However, the %NAT lost the correlation with Glu, but it kept the correlation with GPE, Cr, NAA and 
GABA, and showed additionally significant positive correlation with GPC and Lac. The correlations of 
FA were in general improved. Regarding to the correlations among the metabolites, PE only kept the 
correlations with Pi and Gln, which were improved. Cho showed only significant correlation with Ala and 
Tau. GPC lost the correlation with Gln and GSH but increased the correlation with Lac, Cr, NAA, GABA 
and Ade. The Cr improved all the correlations (GPE, GPC, Lac, Glu, NAA, GABA, mI and Ade) but the 
correlations with Pi disappeared (see the Table 4 and the Table S4 in Electronic Supplementary Material). 
The pH showed a negative correlation with the concentrations of GPE, GPC, Lac, Ade, NAA, GABA and 
Cr and with the sum of %NAT and %Tum, but there was a positive correlation with %Nec. The whole 
map of significant correlations (r and p values) among the metabolites, the pH and the histological data 
post-HRMAS are shown in Table 4S for the GBM group. 
No significant correlation was found between the grade of gliomas and the concentration of metabolites 
but the number of tumour samples other than GBM was too small to be considered. Nevertheless, slight 
differences between the means of low and high grade distributions were observed for some metabolites 
such as GPC and Cho/Cr ratio that were completely lost when the content of tumor or necrosis where 
considered (weighting by the corresponding percent values). 
Additionally a series of 1H spectra were recorded covering a time interval of several hours and checked 
for progressive changes in the metabolic contents. The concentration of some metabolites as Lac, Cr or 
Tau remained almost constant for several hours. Other metabolites as Ala, mI, Cho, GABA, Asp and Glu 
slowly rose, whereas others like GPC, NAA, Gln and Ade had the opposite tendency, slowly decreasing 
with time. 
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Changes in the 1H chemical shift with pH  
The average calculated pH values derived from 31P chemical shift changes for each tumour type are 
gathered in the Table 1 (see the calculated pH value for each sample in the Table S1 in Electronic 
Supplementary Material). The assignment of the signals in 1H showed slight changes for some 
metabolites (data not shown). Looking for some parallelism that can provide us with an estimation for the 
pH values based in the chemical shift change of these metabolites in 1H spectra, a significant (p < 0.001) 
correlation of 0.86 between pH values and the difference in chemical shift of PC and Cho was found 
(Figure 4). A much lower correlation (0.41 p = 0.02) was found for the difference in 1H chemical shift 
between GPC and PC and not significant correlation between GPC and Cho was observed. Also, not 
correlation was found in general with the absolute chemical shift value of PC, but a correlation of 0.90 (p 
< 0.0001) was found between pH and the absolute chemical shift of PC within the group of samples with 
MDPA. 
Possible effect of MDPA 
A significant (p < 0.01) drop of pH (-0.5 units) was found in the group of samples with MDPA compared 
to the rest of the samples prepared without MDPA. This decrease was observed even when MDPA was 
used at concentration as low as 2 µM, which is in the order of the concentration usually found in the 
literature [16]. 
Considering only those samples without MDPA, a correlation of 0.59 (p < 0.01) was found between the 
concentration of H+ (calculated as 10-pH) and the total content (number of moles) of Lac. When Lac and 
Glu amounts were added the correlation increased to 0.65 (p < 0.01). When all the samples were 
considered (with and without MDPA) these correlations were lost. Nevertheless, when the samples with 
the lowest pH (9, 12 and 24 in the Table 1) were removed from the analysis, there was a significant 
correlation of H+ concentration and Lac (0.49 p < 0.01) and also for the sum of Lac and Glu (0.51 p < 
0.01) lower than before. For MDPA + Lac + Glu the correlation with H+ improves to 0.56 (p < 0.01). 
No correlation was found between the pH values and the extension of necrosis or tumour content. The 
same can be said regarding to the tumoral type or grade in the gliomas group. Nevertheless, when only 
the samples without MDPA were considered, the values of pH showed a significant correlation with the 
values of %Tum (correlation of -0.74 p<0.001) and %Tum + %NAT (correlation -0.79 p<0.001). 
 
DISCUSSION 
The study of tissues by HRMAS can be considered an intermediate step between the in vivo study of the 
patient and the in vitro study of the extract of metabolites from the excised tissue [37]. The use of 
HRMAS improves the resolution, allowing the detection and quantification of a great number of 
metabolites and FA [1-4], but sometimes the 1D 1H spectra are too crowded to allow an unequivocal 
identification of some overlapped resonances.  
As it is well known, one advantage in 31P spectra is the dispersion of the signals, greater than in 1H 
spectra (as seen in the Figure 1 and the Figure 2). This enables, among other possibilities, the independent 
evaluation of PE and GPE with relevant biochemical information, and whose signals in the 1H spectra are 
multiplets in areas crowded by signals from other metabolites, usually more intense, and are difficult to 
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detect only with 1D 1H spectra [38]. Moreover, in this study, the acquisition of 2D 1H-1H TOCSY and 1H-
31P HSQC correlation spectra has enabled the identification of the spin systems for the main metabolites 
in 31P spectra and has confirmed the assignments with the homonuclear and the heteronuclear 
correlations. Previously it had been demonstrated that the metabolic information could be improved by 
the combination of 1D 1H and 31P spectra, constructing afterwards a kind of virtual 2D heteronuclear 
correlation [18, 39]. This 1D heteronuclear strategy has been applied in human to the study of gut 
biopsies to detect different tissue microenvironments [18] and in rat liver for the detection of drug-
induced hepatotoxicity [39]. The study here presented, has shown the feasibility of 1H-31P HSQC spectra 
acquisition on human brain tumour tissue with signal to noise ratio adequate to observe the signals from 
the main metabolites identified in the 31P 1D spectra, as shown in the Figure 2. The performance of 1H-31P 
HSQC spectra on these tissues has been very useful to directly and unequivocally confirm the 31P 
assignments with the 1H connected, following the whole set of 1H and 31P resonances in both 1H-31P 
HSQC and 1H-1H TOCSY, regardless of the pH which makes challenging the assignments in 1D 31P  
spectra.  The 1H-1H TOCSY crosspeaks have contributed to confirm those resonances observed in the 31P 
spectra but which are not properly observed in the 1D 1H  spectra since these 1D spectra are usually very 
crowded, as shown in the Figure 2.  
Additionally, a remarkable advantage of the 31P spectra is that allow an estimation of the pH inside the 
tissue samples, that relies in the change in the chemical shift of some phosphorylated metabolites present 
in the living tissues. Unfortunately, some of them, as for example PCr, are very labile and cannot be 
found in the samples from excised tissues [16]. In this work, GPC has been used as an alternative 
metabolite usually present in this kind of samples, since its chemical shift in 31P spectra remains invariant 
with the pH. Furthermore, solutions of known concentration and pH have allowed here to crosscheck the 
consistency of the pH measurements.  
The use of MDPA as a standard compound for reference in 31P NMR studies in tumour tissue has been 
studied here and has shown some drawbacks that precluded its use as seen in this study and in the 
bibliography [16]. The MDPA signal should have been invariant for all the samples but, on the contrary, 
it showed changes in the intensity, the chemical shift and the width. The changes in the intensity and in 
the width indicated that the MDPA might be interacting with the sample since on one hand, the higher the 
quantity of tumour tissue sample was inside the rotor, the lower the amount of MDPA was detected, and 
on the other hand, the higher was the mass of the sample, the wider was the signal of MDPA. The 
experimental procedure of sample preparation might have introduced some minor error in the 
quantification since some small but undetermined quantity of the reference might have escaped from the 
rotor if the preparation was not performed carefully. However, the data in this study mainly points to the 
interaction between the MDPA and the sample, since both, the intensity and the width changed through 
the different samples studied with MDPA. According to this, the addition of MDPA as a concentration 
reference for tissue samples would not be convenient. Furthermore, the signal of MDPA also showed 
changes in the chemical shift and in the width related with the pH which makes it unsuitable as an 
absolute reference for chemical shift. In already published data a variability in the intensity of MDPA 
inside the rotor was detected [16] but the chemical shift of MDPA was assumed invariant. In fact, 
according to the data in the reference [16], the pH variability of these grown tumours was ± 0.09 pH 
units, which is not supposed to shift the MDPA signal in the whole set of samples. The samples on the 
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study of Payne et al. [16] were 15 samples from the same kind of homogeneous tumour and with little 
necrosis and few cystic regions and the authors did not mention pH changes along the series. On the 
contrary, in our study the 15 samples studied with MDPA were samples from real patients, mainly GBM 
(14/15), the highest glioma grade inherently heterogeneous [40], with very variable pH and proportions of 
tumour, necrosis and normal appearing tissue, as determined in the histological study whose results are 
shown in the Table 1 and Table S1. Finally, it deserves to be mentioned the effect of MDPA in the value 
of pH itself, as deduced from the changes in the pH (-0.5 pH units) in the samples with MDPA, compared 
to the samples without MDPA, and from the improvement of correlation of the pH with the concentration 
of metabolites that could account for the total concentration of H+.  
All these drawbacks for the MDPA prevent the use of standard compounds as a concentration reference, 
and suggest the use of other strategies, as ERETIC digital synthetic signal, that can be added in the post-
processing of the spectra and that only requires the calibration with the data from a standard solution, 
acquired with the same experimental conditions and with the same sequence. This strategy had been 
previously presented in the study of human ovarian epithelial carcinomas tissue [23] with 1D 1H Carr-
Purcell-Meiboom-Gill pulse experiments. The electronically generated signal of ERETIC had already 
been presented in the quantification of 1D 1H spectra of human brain tissues [7]. The results obtained 
using ERETIC digital synthetic signal clearly show that it can successfully be applied to the 
quantification of 1D 31P and 1H spectra of human brain tumour tissues. The high correlation observed 
between the quantification by 1H and 31P spectra, as shown in the Figure 3 and in the Table 3 for PC and 
GPC  validates the use of ERETIC digital synthetic signal also for the 31P spectra in tissues.      
The pH has been a matter of interest in the study of biological samples since it is part of the physiological 
information that can be obtained from the tissue and can help in the characterization of a normal or a 
pathological state. The study of the pH in tissues in vivo or ex vivo has been usually relied upon 31P NMR 
experiments, but the same metabolites that undergo changes in chemical shift in the 31P resonances, may 
show changes in 1H resonances near to this group or other resonances close to labile protons. There are 
several compounds seen in the 1H spectra whose chemical shifts has been shown to change with pH (Cr, 
Gly, Acetate) [41] but the range in which these changes occur is out of the pH interval seen in the samples 
here studied. Previous studies on human brain tumour biopsies already reported slight changes on the 
chemical shift of metabolites in 1H 1D spectra, For instances, the chemical shift of Gln was possibly 
related with the pH [2] but did not show any consistent pattern between or within the tumor types. 
Histidine has shown changes in the chemical shift of H4 and H2 [41, 42] that occur in the interval of pH 
observed in the samples here studied, but unfortunately, Histidine has not been detected among the 
metabolites here assigned. Several studies have dealt with the pH and 1H spectra, either from the point of 
view of assessment of the pH [41] or with the objective of searching the pH in which the chemical shifts 
of the metabolites may be invariant [43]. In the first case, as before mentioned, the range of pH closer to 
the pH in these samples could be determined using the chemical shift of Histidine. The changes of δ PC 
vs Cho at pH interval between 5 and 7.5 observed in this study are in agreement with the changes in δ of 
PC in the 31P and also with the pKa of PC that is 5.76 [14].  GPC, PC and Cho 1H N(CH3)3 resonances did 
not change vs TSP at pH interval between 7 and 10 [43]. Nevertheless, the data here presented are in a pH 
interval closer to pKa of PC. The changes observed here are very slight, probably due to the relatively 
long distance between N(CH3)3 protons and the phosphate which undergoes protonation changes with the 
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pH. This is indeed a weak correlation for precise pH determination but it could provide a broad 
estimation, at least about if the sample is “better neutral” or “better acid”. Another issue to be considered 
is the effect in the chemical shift of a metabolite inside of the tissue.  It has been recently demonstrated 
tissue-specific differences between frequency distances of water and metabolites [44] comparing gray 
matter and white matter.  
The number of tumours here studied with different histological grading is too reduced to found a 
statistical reliable correlation between the tumour grade and the metabolic changes detected. 
Nevertheless, the essential histological features of %Nec, %Tum and %NAT have been determined and 
several important correlations among the concentration of different metabolites and the histology data 
have been found. 
Noteworthy, significant correlations have been found between %Tum and Gln, PE+PC, FA, Glu/Gln, and 
Cho/Cr. The fact that we obtained a higher correlation with GPC, PC, Cr, Gln, Ade, when it was 
considered the sum %Tum + %NAT suggested that the correlations observed with the %Tum sometimes 
may be due to the presence of viable cells (either tumour cells or normal cells, and after suffering some 
degree of damage) and not specific of the tumoral ones. It seems that a general agreement was found 
through a positive correlation between energetic metabolism intermediates and the %Tum + %NAT 
content as well as negative correlation with %Nec. The reverse situation was found respect to FA 
concentration, something commonly observed in the literature [35]. Actually, the proportions of these 
features are the responsible for the final tumour grade classification [40]. 
The absence of correlations between Lac or pH and %Tum led us to consider them as a consequence 
mainly of the anoxic conditions suffered after removal of the tissue sample. However, it is quite difficult 
to establish the contribution of the tumor effect in these parameters [45]. It is expected a combined 
contribution from both processes, the anoxic and the tumour. The observed correlation between the pH, in 
the group without MDPA, with %Tum + %NAT seems to indicate that the pH is mostly related to the 
total cell content under anoxic conditions more than to only tumour content.  
Lac showed a high correlation with Ala and Tau, maybe because the period of anoxic metabolism. 
Moreover, Tau showed correlation with GSH, both of them are perhaps also related with protective 
properties (they have in common an antioxidant effect, and additionally Tau could be implied in the 
stabilization of the membrane and the inhibition of neurotransmission). PC showed correlation with Pi 
and GSH. 
For the GBM subset of samples similar results were obtained but the correlations observed were 
increased. New positive correlations with %Tum appear for GSH, PC and mI. A negatively correlation 
was observed with GSH and %Nec (these could be the first effects of tissue deterioration due to tumor 
effect). There was observed a clear correlation among GPE, GPC, Cr, NAA and GABA. All of them are 
clearly connected with the content of non-affected tissue. 
There was an evident correlation between %Nec and the decrease of some metabolites, particularly Cr but 
also with the decrease of Gln, GPC, GABA and Ade, and the raising in the concentration of signals from 
FA. When only GBM samples were considered the correlations were improved, and the set of metabolites 
which showed significant descent with %Nec included also PC, Lac, Glu, GSH and mI. This variation, in 
spite of showing a significant correlation, is not exactly linear: a broad lowering of Cr, Glu, GABA, 
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NAA, mI, and other metabolites was observed when %Nec increased. This is probably connected with a 
general decay in the tissue sample. Nevertheless, a low percentage of necrotic areas does not necessarily 
imply a high concentration of these metabolites which suggests that the deterioration in the cells is not 
entirely due to extensive necrosis, but also apoptosis or other cell deterioration processes that can take 
place. On one hand, changes in the FA signals have been observed following apoptosis, necrosis or lipid 
droplet formation [35, 46-48]. On the other hand it has been observed in vivo that MRS-visible lipids 
accumulate with apoptosis [49], suggesting that these signals of FA may serve as a surrogate marker for 
apoptosis detected in vivo by 1H MRS[50]. 
There are different ways for tissue deterioration and it is difficult knowing which one is the most 
important and when it occurs. It could happen in vivo under the tumor growth effects, ex vivo during 
excision and freezing or during the NMR experiments. The series of HRMAS experiments acquired at 
6ºC revealed that no appreciable variation of the concentration was observed in the first 40 minutes of 
acquisition and that only slow but appreciable variations were observed if extended for hours. 
Nevertheless, it is known that a time interval as short as 5 minutes is enough to develop anoxic conditions 
that produce important variations in the concentrations of metabolites [51]. In the data here obtained there 
were several indicatives of anoxic conditions: the high concentration of Lac, the low values of pH (that 
was not completely explained by the increase in Lac), the depletion of all energetic metabolic stores 
(ATP, PCr) and the presence of adenosine. Adenosine is an intermediate metabolite accumulated in stress 
conditions and has been recognized as implied in cytoprotection during ischemia or anoxia [52]. 
According to these observations, these conditions occurred previous to the NMR study, probably in the 
time between the surgery and the freezing of the sample. But some contribution from the tumoral growth 
cannot be discarded.  
The great heterogeneity of the samples here analyzed, intrinsic by the tumour type, can be clearly 
observed in the histological examples of Figure 1, in the % of Tum, Nec and NAT in Table 1 and in the 
great variability of the concentrations of most of the metabolites detected. This is particularly evident in 
the GBM group, a type of tumour generally recognized as very heterogeneous [40]. The samples studied 
by HRMAS are frequently a small part of the original tumour piece and then can be considered as a 
partial representation when the tumor is not a homogeneous piece. Then, we must take into account both, 
the variable characteristics among different cases, and the internal heterogeneity of each one. These 
differences influence the conditions of the tissue sample during the HRMAS experiments after which 
considerable alterations and damage of the sample have been observed [25]. The metabolite profile of the 
tumor samples reflects the physiological state of the living tissue but can also reveal the conditions 
suffered by the sample during manipulation. In some circumstances the last can have a preponderant 
influence in the final profile even masking the original state. The changes in the metabolite concentrations 
can be very fast and then the metabolome is an instantaneous characterization of the state of a tissue when 
compared with the one provided by proteome or genome.  
 
Conclusion 
In this study the pH and the absolute concentrations of a set of metabolites in human brain tumor samples 
have been determined trough the analysis of 1H and 31P spectra by HRMAS, using the digital ERETIC 
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synthetic signal as a concentration reference, and homo and heteronuclear correlation experiments to 
follow the 1H-1H and 1H-31P spin systems and to confirm the assignments. The use of MDPA as a 31P 
chemical shift and concentration reference has shown some drawbacks according to the demonstrated 
interaction between this compound and the tissue, considering a better approach the use of the ERETIC 
strategy for quantification either in 1H or in 31P experiments in tissues, and the use of endogenous 
substances whose chemical shift is known to be invariant with pH. Finally, the combination of 1H and 31P 
information has made possible to assess the correlation between the slight changes in chemical shift of 
some metabolites as PC and GPC with the pH. 
The study of the main histological features of the samples has enabled to check the relation between the 
changes in the absolute concentration of the metabolites and the percentage of Tumour, Necrosis and not 
apparently tumour tissues. Two superposed effects have occurred in a manner that can be explained 
trough the physiological facts that may occur in the tumour or during the handling of the excised tissue. 
The alterations of the concentrations of characteristic brain metabolites that we have determined give 
some support to the idea that the mixture of tissues and deterioration on each type of tumour is what can 
be directly detected in the metabolic profiles by HRMAS, and the characterization of each type of tumour 
and degree relies on the characteristic contributions of such alterations.  
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Table 1 This table details the types of tumour studied. For each group the average and the standard 
deviation is provided for the pH and for the tissue percentage composition, evaluated in the histological 
analysis after HRMAS: tumoral tissue (%Tum), extensive necrosis (%Nec) and non affected tissue 
(%NAT). In the tumour type column, GBM means Glioblastoma Multiforme (grade IV Glioma) 
Table 2 Concentrations (average±standard deviation μmol/g) of the more abundant metabolites evaluated 
by integration of the corresponding signals and using ERETIC digital as reference in each group of 
tumour. The quantification presented in this table is restricted to only one of the signals in each 
metabolite. Nevertheless, for GPC and PC we have included the quantification of the concentration 
obtained using both the 1H and 31P spectra for comparative purposes. For the fatty acids resonances, the 
values in this table represent the average concentration of these characteristics groups and not the 
concentration of independent molecules. FA 1,  –CH2-CH3;  FA 2,  –CH2-CH2-CH2-;  FA 3,  –CO-CH2-
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CH2-;  FA 4  –CH2-CH=CH-;  FA 5, –CO-CH2-; FA6 and FA7, -CH=CH-CH2-CH=CH-;  FA8, -
CH=CH- 
Table 3 Significant correlations between the concentrations of metabolites, pH and proportions of 
different tissue types present in the samples analyzed. Only correlation coefficient for correlations with 
p<0.01 have been shown 
a Data from 31P spectra. Otherwise, data from 1H spectra. 
b Only data for FA1 is presented since the correlations of FA group with the metabolites, pH and tissue 
features is similar. For a complete set of FA data see Table S3B in Electronic Supplementary Material. 
Table 4 Significant correlations between the concentrations of metabolites, FA signals, pH and 
proportions of different tissue types present in the samples analyzed restricted to the group of samples 
diagnosed as GBM. Only correlation coefficient for correlations with p<0.01 have been shown.  
a Only data for FA1 is presented since the correlations of FA group with the metabolites, pH and tissue 
features is similar. For a complete set of FA data see Table S4 in Electronic Supplementary Material. 
 
Tables in Electronic Supplementary Material: 
Table S1 List of samples studied with specification of the type of tumor of origin, weight and pH 
evaluated using the 31P chemical shifts as explained in materials and methods. For each sample there is 
also included three tissue percentage composition evaluated in the histological analysis after HRMAS: 
tumoral tissue (%Tum), extensive necrosis (%Nec) and non affected tissue (%NAT). In the tumour type 
column, GBM means Glioblastoma Multiforme; AA, anaplastic astrocytoma; ODAA, anaplastic 
oligodendroastrocytoma; OD, oligodendroglioma; ODA, oligoastrocytoma; AI, grade I astrocytoma; 
MET, metastases; MEN, meningeoma; TER, teratoma 
Table S2A Concentrations (μmol/g) of the more abundant metabolites evaluated by integration of the 
corresponding signals and using ERETIC digital as reference. The quantification presented in this table is 
restricted to only one of the signals in each metabolite. Nevertheless, for GPC and PC we have included 
the quantification of the concentration obtained using both the 1H and 31P spectra for comparative 
purposes 
a Data from 31P spectra. Otherwise, data from 1H spectra. 
Table S2B Quantification of characteristic fragments of fatty acids deduced of the broad signals observed 
at typical chemical shift. The values represent the concentration of these characteristics groups and not 
the concentration of independent molecules. FA 1,  –CH2-CH3;  FA 2,  –CH2-CH2-CH2-;  FA 3,  –CO-
CH2-CH2-;  FA 4  –CH2-CH=CH-;  FA 5, –CO-CH2-; FA6 and FA7, -CH=CH-CH2-CH=CH-;  FA8, -
CH=CH- 
Table S3A Significant correlations between the concentrations of metabolites, pH and proportions of 
different tissue types present in the samples analyzed. Normal font in half upper right part of the table 
expresses correlation coefficient, and data in italics in the lower left part of the table expresses the 
corresponding p value. Only data for correlation with p<0.05 have been shown 
a Data from 31P spectra. Otherwise, data from 1H spectra. 
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Table S3B Significant correlations between the quantification of different FA signals, pH and proportions 
of different tissue types present in the samples analyzed. Data presentation follows the same criteria than 
table 3A 
Table S4 Significant correlations between the concentrations of metabolites, FA signals, pH and 
proportions of different tissue types present in the samples analyzed restricted to the group of samples 
diagnosed as GBM. Data presentation follows the same criteria than table 3A 
 
Fig. 1 Comparison of three different patterns of tissue configuration in samples extracted from tumours 
diagnosed as GBM and the corresponding stained tissue slice (left), 1H (centre) and 31P (right) spectra. 
Upper, sample 1 (4% Tum, 96.0% Nec, 0.0% NAT): extensive necrosis dominates the sample, low 
signals of metabolites and prominent signals of FA can be appreciated in the 1H and 31P. Centre, sample 7 
(94.2% Tum, 5.8% Nec, 0.0% NAT) dense tumoral cell growth (higher amounts of metabolites and lower 
of FA are present). Down, sample 10 (46.1% Tum, 1.0% Nec, 52.8% NAT): border tissue with dense 
tumoral growth is clearly delimited in this case; the signals of metabolites area also prominent, but 
present very different proportions. All the quantified signals are assigned except the signals of FA8 and 
Adenosine which are out of the region showed in the spectra 
Fig. 2 1H-31P HSQC (up) and TOCSY (down) spectra with the correspondent 1D 1H and 31P spectra for 
the sample 10. The displayed region in the TOCSY show the 1H-1H XP-O-CH2-CH2-NX crosspeaks in 
the TOCSY for GPC, PC, GPE and PE. The 1H-31P HSQC region in the figure shows with higher 
intensity the 1H-31P crosspeaks of XP-O-CH2-CH2-NX of GPC, PC, GPE and PE, and CH2OH-CHOH-
CH2-PO4-CH2-… of GPC and GPE. Less intense but also appear the crosspeaks of XP-O-CH2-CH2-NX 
for GPE and GPC. The path of homo-heteronuclear assignments are drawn in dashed line in blue for 
GPC, in red for GPE, in green for PC and in yellow for PE. The signals can be observed in the 
correspondent 1D 31P spectrum on the right margin of HSQC spectrum, but not in the 1D 1H crowded 
spectra on top of HSQC spectrum 
Fig. 3 The evaluation of the signals was performed correcting for the overlapping nearby peaks as 
illustrated here for the case of creatine CH2 protons (upper left). The posterior quantification of the 
creatine concentrations showed a good correlation between the evaluations using the CH2 and the CH3 
signals (>0.99 with p<0.001; upper right). The comparison of concentrations calculated using 1H and 31P 
spectra for PC (0.94, p<0.001; lower left) and GPC (0.92, p<0.001; lower right) showed also an internal 
consistency of the quantification method 
Fig. 4 Linear fit for pH versus the chemical shift difference between Cho and PC N(CH3)3 protons 
evaluated in 1H water presaturation spectra (correlation coefficient 0.86, p< 0.001). The dotted lines 
represent the 95% prediction bounds and show that only a broad estimation of the pH (approximately ± 
0.45 pH units) is possible from the measured chemical shift difference 
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